Does ADO-TRASTUZUMAB EMTANSINE Cause Conjunctivitis? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Conjunctivitis have been filed in association with ADO-TRASTUZUMAB EMTANSINE. This represents 0.5% of all adverse event reports for ADO-TRASTUZUMAB EMTANSINE.
44
Reports of Conjunctivitis with ADO-TRASTUZUMAB EMTANSINE
0.5%
of all ADO-TRASTUZUMAB EMTANSINE reports
16
Deaths
10
Hospitalizations
How Dangerous Is Conjunctivitis From ADO-TRASTUZUMAB EMTANSINE?
Of the 44 reports, 16 (36.4%) resulted in death, 10 (22.7%) required hospitalization, and 3 (6.8%) were considered life-threatening.
Is Conjunctivitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADO-TRASTUZUMAB EMTANSINE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does ADO-TRASTUZUMAB EMTANSINE Cause?
Nausea (780)
Fatigue (774)
Disease progression (750)
Diarrhoea (654)
Off label use (630)
Thrombocytopenia (519)
Death (509)
Neuropathy peripheral (506)
Headache (465)
Platelet count decreased (453)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
SECUKINUMAB (237)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
Which ADO-TRASTUZUMAB EMTANSINE Alternatives Have Lower Conjunctivitis Risk?
ADO-TRASTUZUMAB EMTANSINE vs ADRIAMYCIN
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB
ADO-TRASTUZUMAB EMTANSINE vs ADUCANUMAB-AVWA
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR
ADO-TRASTUZUMAB EMTANSINE vs ADVAIR HFA